[德国医学科学院指南：可卡因、安非他命、摇头丸及致幻剂相关障碍]

[AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders].

作者信息

Thomasius R, Gouzoulis-Mayfrank E, Karus C, Wiedenmann H, Hermle L, Sack P M, Zeichner D, Küstner U, Schindler A, Krüger A, Uhlmann S, Petersen K U, Zapletalova P, Wartberg L, Schütz C G, Schulte-Markwort M, Obrocki J, Heinz A, Schmoldt A

机构信息

Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Hamburg-Eppendorf.

出版信息

Fortschr Neurol Psychiatr. 2004 Dec;72(12):679-95. doi: 10.1055/s-2004-818531.

DOI:10.1055/s-2004-818531

PMID:15580533

Abstract

Actually, guidelines for treatment of substance-related disorders were written under the overall control of the DG-Sucht e. V. and the DGPPN e. V. This appears within the framework of the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaft (AWMF). The leading objective of these guidelines is the description of the current scientifically proven and evidence-based medicine in addiction to derive recommendations to therapy. In this context, the guideline for treatment of cocaine-, amphetamine-, ecstasy-, and halluzinogen-related disorders is introduced.

摘要

实际上，物质相关障碍的治疗指南是在德国成瘾问题协会（DG-Sucht e. V.）和德国精神病学、心理治疗与神经病学协会（DGPPN e. V.）的全面控制下编写的。这是在科学医学专业协会工作小组（AWMF）的框架内进行的。这些指南的主要目标是描述当前经科学验证且基于证据的成瘾医学，以得出治疗建议。在此背景下，引入了可卡因、安非他命、摇头丸和致幻剂相关障碍的治疗指南。